[HTML][HTML] The role of population PK–PD modelling in paediatric clinical research

RFW De Cock, C Piana, EHJ Krekels, M Danhof… - European journal of …, 2011 - Springer
Children differ from adults in their response to drugs. While this may be the result of changes
in dose exposure (pharmacokinetics [PK]) and/or exposure response (pharmacodynamics …

Tips and traps analyzing pediatric PK data

BJ Anderson, NHG Holford - Pediatric Anesthesia, 2011 - Wiley Online Library
Pharmacokinetic (PK) and pharmacodynamic (PD) modeling has elucidated aspects of
developmental pharmacology of value to the anesthetic community. The increasing …

The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver

SJ Miyagi, AC Collier - Drug Metabolism and Disposition, 2011 - ASPET
UDP-glucuronosyltransferases (UGTs) are critical for the metabolism and clearance of
drugs, chemicals, and hormones. The development of UGT1A1 and 1A6 was studied in 50 …

Neonatal pharmacology: extensive interindividual variability despite limited size

C Tayman, M Rayyan… - The Journal of Pediatric …, 2011 - meridian.allenpress.com
Providing safe and effective drug therapy to neonates requires knowledge of the impact of
development on the pharmacokinetics and pharmacodynamics of drugs. Although …

Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans

JW Fisher, NC Twaddle, M Vanlandingham… - Toxicology and Applied …, 2011 - Elsevier
A physiologically based pharmacokinetic (PBPK) model was developed for bisphenol A
(BPA) in adult rhesus monkeys using intravenous (iv) and oral bolus doses of 100μgd6 …

Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children

SN de Wildt - Expert opinion on drug metabolism & toxicology, 2011 - Taylor & Francis
Introduction: There are profound changes that take place in drug metabolism enzymes
during fetal and postnatal development. These changes may significantly impact drug …

[HTML][HTML] Systematic evaluation of the descriptive and predictive performance of paediatric morphine population models

EHJ Krekels, JGC van Hasselt, D Tibboel… - Pharmaceutical …, 2011 - Springer
Purpose A framework for the evaluation of paediatric population models is proposed and
applied to two different paediatric population pharmacokinetic models for morphine. One …

Predictive performance of a recently developed population pharmacokinetic model for morphine and its metabolites in new datasets of (preterm) neonates, infants and …

EHJ Krekels, J DeJongh, RA van Lingen… - Clinical …, 2011 - Springer
Abstract Background and Objective Model validation procedures are crucial when models
are to be used to develop new dosing algorithms. In this study, the predictive performance of …

Individualized dosing regimens in children based on population PKPD modelling: are we ready for it?

CAJ Knibbe, M Danhof - International journal of pharmaceutics, 2011 - Elsevier
Despite profound differences in response between children and adults, and between
children of different ages, drugs are still empirically dosed in mg/kg in children. Since …

Advances in paediatric pharmacokinetics

CAJ Knibbe, EHJ Krekels, M Danhof - Expert opinion on drug …, 2011 - Taylor & Francis
Importance of the field: In recent years, interest in paediatric pharmacokinetics has grown.
Even though pharmacokinetic and pharmacodynamic relations determine together the …